CardioComm Solutions announces first European marketing agreement for GlobalCardio

Victoria 06 March 2003CardioComm Solutions Inc. has entered into an exclusive agreement with Meditel Srl of Milan, Italy. The agreement establishes Meditel as the exclusive customer for CardioComm's GlobalCardio in Italy for a minimum period of eighteen months. Meditel will provide, on an exclusive basis, interpretation services involving the recording of ECGs and interpretation of ECGs for health centres in Italy.

Advertisement

Meditel will provide enrolling/interpreting physicians and health centre users with telemedicine-cardiology services through GlobalCardio. Meditel promotes innovative telemedicine services through the Italian pharmacy network. Its primary focus of service lies within the field of cardiology, with 12 leads ECG diagnosis, arrhythmia loop event monitoring and ambulatory blood pressure monitoring.

In Italy, there are more than 16.000 pharmacies. From a recent market research, 79,8 percent of the Italian population is interested in using new innovative diagnostic services offered by pharmacies.

The remote ECG management and interpretation is done with the use of the GlobalCardio system. The clinical service is managed by a group of specialists under the name of MediWebNet who's President, Dr. Roberto Rocci, was a member of the Telemedicine Experts Commission at the Ministry of Health in Italy. Dr. Rocci is a world-renowned cardiologist recognised for his knowledge and implementation of telemedicine.

CardioComm's patented and proprietary technology is used in products for the recording, viewing, analysing and storing of electrocardiograms (ECGs), for diagnosis and management of cardiac patients. CardioComm has achieved its technical goals of improved access and communication through the development of a real-time ECG viewer.

CardioComm is the first company to provide a real-time means of viewing ECGs over a network such as LAN, WAN or Internet. This tool enables ECGs to be viewed and controlled live, by physicians, over a global virtual health care network. This technology is marketed as Global ECG Management System (GEMS) and GlobalCardio. CardioComm's software products have been cleared for sale in the United States by the U.S. Food and Drug Administration. The company has both ISO 9001 and EN 46001 certifications.


Leslie Versweyveld

[Medical IT News][Calendar][Virtual Medical Worlds Community][News on Advanced IT]